An Open Label Balanced Study in Healthy Subjects to Evaluate the Potential for Cytochrome P 450 3A4 Induction by Oral OC000459 Using Oral Midazolam as a Probe.

Trial Profile

An Open Label Balanced Study in Healthy Subjects to Evaluate the Potential for Cytochrome P 450 3A4 Induction by Oral OC000459 Using Oral Midazolam as a Probe.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jan 2013

At a glance

  • Drugs OC 459 (Primary) ; Midazolam
  • Indications Allergic rhinitis; Anxiety disorders; Asthma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Sep 2010 Actual initiation date added to 1 Feb 2010 as reported by ClinicalTrials.gov.
    • 01 Sep 2010 Actual end date added to 1 May 2010 as reported by ClinicalTrials.gov.
    • 01 Sep 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top